All News Biogen Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
215.5 ^USD	+3.16%		+11.02%	-16.72%

Apr. 29	Wall Street: buoyed by Tesla, confident ahead of FOMC meeting	CF
Apr. 26	Guggenheim Adjusts Price Target on Biogen to $255 From $275	MT

Wall Street: buoyed by Tesla, confident ahead of FOMC meeting	Apr. 29	CF
Guggenheim Adjusts Price Target on Biogen to $255 From $275	Apr. 26	MT
Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®	Apr. 25	GL
Biogen Inc. Receives Positive CHMP Opinion for TOFIDence (tocilizumab), a Biosimilar Referencing ROACTEMRA	Apr. 25	CI
Goldman Sachs Adjusts Biogen Price Target to $340 From $393	Apr. 25	MT
Canaccord Genuity Adjusts Price Target on Biogen to $308 From $305	Apr. 25	MT
Barclays Adjusts Price Target on Biogen to $200 From $215	Apr. 25	MT
HC Wainwright Adjusts Biogen's Price Target to $300 From $325	Apr. 25	MT
Wedbush Adjusts Price Target on Biogen to $215 From $213	Apr. 25	MT
Health Care Down Amid Mixed Earnings -- Health Care Roundup	Apr. 24	DJ
Tranche Update on Biogen Inc.'s Equity Buyback Plan announced on October 21, 2020.	Apr. 24	CI
Biogen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Sector Update: Health Care Stocks Slipping Late Afternoon	Apr. 24	MT
News Highlights : Top Company News of the Day - Wednesday at 3 PM ET	Apr. 24	DJ
Wall St edges lower as rising yields overshadow upbeat corporate results	Apr. 24	RE
Morgan Stanley Cuts Biogen's Price Target to $331 From $339	Apr. 24	MT
Sector Update: Health Care Stocks Softer Wednesday Afternoon	Apr. 24	MT
Sector Update: Health Care	Apr. 24	MT
Piper Sandler Raises Biogen's Price Target to $335 From $325	Apr. 24	MT
RBC Lowers Biogen's Price Target to $317 From $326	Apr. 24	MT

No results for this search